Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Michailidis, Eleftherios" or (type any "bookEditor journalEditor issueEditor" and editor=...

Add to list
- Journal Article
- A1
- open access
Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

Danyel Lee, Jérémie Le Pen, Ahmad Yatim, Beihua Dong, Yann Aquino, Masato Ogishi, Rémi Pescarmona, Estelle Talouarn, Darawan Rinchai, Peng Zhang, et al.

(2023) SCIENCE. 379(6632).
Add to list
- Journal Article
- A1
- open access
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina Garcia-Prat, et al.

(2022) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 119(21).
Add to list
- Journal Article
- A1
- open access
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina Garcia-Prat, et al.

(2021) SCIENCE IMMUNOLOGY. 6(62).
Add to list
- Journal Article
- A1
- open access
Experimental variables that affect human hepatocyte MV transduction in liver chimeric mice

Chenhui Zou, Koen O.A. Vercauteren, Eleftherios Michailidis, Mohammad Kabbani, Irene Zoluthkin, Corrine Quirk, Luis Chiriboga, Mustafa Yazicioglu, Xavier M. Anguela, Philip Meuleman (UGent) , et al.

(2020) MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 18. p.189-198
Add to list
- Journal Article
- A1
- open access
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes

Eleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, Linda Andrus, Cyprien Jahan, Inna Ricardo-Lax, Chenhui Zou, Mohammad Kabbani, Paul Park, Corrine Quirk, et al.

(2020) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117(3). p.1678-1688
Add to list
- Journal Article
- A1
- open access
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice

Richard J. P. Brown, Birthe Tegtmeyer, Julie Sheldon, Tanvi Khera, [missing] Anggakusuma, Daniel Todt, Gabrielle Vieyres, Romy Weller, Sebastian Joecks, Yudi Zhang, et al.

(2020) SCIENCE ADVANCES. 6(45).
Add to list
- Journal Article
- A1
- open access
Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Yu Zhang, Karim Dorgham, Quentin Philippot, Jeremie Rosain, Vivien Beziat, et al.

(2020) SCIENCE. 370(6515).
Add to list
- Journal Article
- A1
- open access
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, Paul Bastard, Zhiyong Liu, Jérémie Le Pen, Marcela Moncada-Velez, Jie Chen, Masato Ogishi, Ira K. D. Sabli, Stephanie Hodeib, Cecilia Korol, et al.

(2020) SCIENCE. 370(6515). p.422-+

Academic Bibliography

Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Experimental variables that affect human hepatocyte MV transduction in liver chimeric mice

Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes

Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Contents

Support

Contact